Wednesday, April 21, 2010

Gilead Falls 10% due to Lower Forecasts

Gilead Sciences shares are trading around 10% lower hovering around $41 after the company issued weaker-than-expected 2010 guidance.The company lowered its 2010 sales forecast by about $200 million to a range of $7.4 billion to $7.5 billion due to the impact of the recently passed health care reform.

No comments: